Enhancement of swine progenitor chimerism in mixed swine/human bone marrow cultures with swine cytokines

被引:12
作者
Emery, DW
Holley, K
Sachs, DH
机构
[1] Massachusetts Gen Hosp, Transplantat Biol Res Ctr, Boston, MA 02129 USA
[2] Harvard Univ, Sch Med, Boston, MA USA
关键词
culture; bone marrow; cytokines; xenogeneic; swine;
D O I
10.1016/S0301-472X(99)00058-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: The induction of transplantation tolerance across xenogeneic barriers by bone marrow transplantation holds great promise, but engraftment of xenogeneic stem cells has been difficult to achieve. Part of this difficulty is due to species-specific differences in regulatory cytokines and elements of the stromal microenvironment, which we studied here. Materials and Methods: We developed a system where fresh bone marrow cells from swine and human are cultured on human bone marrow stroma in order to study these limiting factors in a clinically relevant species combination. Results: We report here the ability of recombinant swine interleukin (IL)-3 and c-kit ligand (KL) to specifically enhance swine hematopoietic chimerism in this system. In the absence of exogenous swine cytokines, there were about half as many swine progenitors as human progenitors at 1, 2, and 4 weeks of culture. When used alone, swine IL-3 led to a notable but transient increase in the relative ratio of swine progenitors, while addition of swine KL increased the ratio of swine progenitors only modestly and only at later time points. In contrast, when swine IL-3 and KL were added together, there was a two- to fourfold increase in the ratio of swine to human progenitors at all times tested. Conclusion: These data demonstrate that both swine IL-3 and KL are needed for prolonged enhancement of swine progenitor chimerism under these conditions, and suggest that the species specificity of either one or both of these cytokines may represent an important barrier to prolonged engraftment of swine bone marrow in humans. (C) 1999 International Society for Experimental Hematology. Published by Elsevier Science Inc.
引用
收藏
页码:1330 / 1337
页数:8
相关论文
共 50 条
[1]  
ANDREWS RG, 1992, BLOOD, V80, P920
[2]  
BODINE DM, 1992, BLOOD, V79, P913
[3]   Inhibition of xenoreactive natural antibody production by retroviral gene therapy [J].
Bracy, JL ;
Sachs, DH ;
Iacomini, J .
SCIENCE, 1998, 281 (5384) :1845-1847
[4]   CLONING AND EXPRESSION OF THE RAT INTERLEUKIN-3 GENE [J].
COHEN, DR ;
HAPEL, AJ ;
YOUNG, IG .
NUCLEIC ACIDS RESEARCH, 1986, 14 (09) :3641-3658
[5]   CONDITIONS CONTROLLING PROLIFERATION OF HEMATOPOIETIC STEM-CELLS INVITRO [J].
DEXTER, TM ;
ALLEN, TD ;
LAJTHA, LG .
JOURNAL OF CELLULAR PHYSIOLOGY, 1977, 91 (03) :335-344
[6]   TRANSPLANTATION OF NORMAL AND LEUKEMIC HUMAN BONE-MARROW INTO IMMUNE-DEFICIENT MICE - DEVELOPMENT OF ANIMAL-MODELS FOR HUMAN HEMATOPOIESIS [J].
DICK, JE ;
LAPIDOT, T ;
PFLUMIO, F .
IMMUNOLOGICAL REVIEWS, 1991, 124 :25-43
[7]   CLINICAL SIGNIFICANCE OF LONG-TERM CULTURES OF MYELOID BLOOD-CELLS [J].
EAVES, AC ;
CASHMAN, JD ;
GABOURY, LA ;
EAVES, CJ .
CRC CRITICAL REVIEWS IN ONCOLOGY/HEMATOLOGY, 1987, 7 (02) :125-138
[8]  
EAVES CJ, 1978, BLOOD, V52, P1196
[9]  
Emery DW, 1996, EXP HEMATOL, V24, P927
[10]  
EMERY DW, 1994, TRANSPLANT P, V26, P1313